187 related articles for article (PubMed ID: 8411367)
1. Identification of the infected target cell type in spongiform myeloencephalopathy induced by the neurotropic Cas-Br-E murine leukemia virus.
Gravel C; Kay DG; Jolicoeur P
J Virol; 1993 Nov; 67(11):6648-58. PubMed ID: 8411367
[TBL] [Abstract][Full Text] [Related]
2. The prion protein gene is dispensable for the development of spongiform myeloencephalopathy induced by the neurovirulent Cas-Br-E murine leukemia virus.
Jolicoeur P; Massé G; Kay DG
J Virol; 1996 Dec; 70(12):9031-4. PubMed ID: 8971038
[TBL] [Abstract][Full Text] [Related]
3. Retrovirus-induced spongiform myeloencephalopathy in mice: regional distribution of infected target cells and neuronal loss occurring in the absence of viral expression in neurons.
Kay DG; Gravel C; Robitaille Y; Jolicoeur P
Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1281-5. PubMed ID: 1847516
[TBL] [Abstract][Full Text] [Related]
4. Substitution of the U3 long terminal repeat region of the neurotropic Cas-Br-E retrovirus affects its disease-inducing potential.
Paquette Y; Kay DG; Rassart E; Robitaille Y; Jolicoeur P
J Virol; 1990 Aug; 64(8):3742-52. PubMed ID: 2164594
[TBL] [Abstract][Full Text] [Related]
5. Temporal central and peripheral nervous system changes induced by a paralytogenic mutant of Moloney murine leukemia virus TB.
Stoica G; Illanes O; Tasca SI; Wong PK
Lab Invest; 1993 Dec; 69(6):724-35. PubMed ID: 8264234
[TBL] [Abstract][Full Text] [Related]
6. Murine retroviral-induced spongiform neuronal degeneration parallels resident microglial cell infection: ultrastructural findings.
Baszler TV; Zachary JF
Lab Invest; 1990 Nov; 63(5):612-23. PubMed ID: 2172651
[TBL] [Abstract][Full Text] [Related]
7. Induction of focal spongiform neurodegeneration in developmentally resistant mice by implantation of murine retrovirus-infected microglia.
Lynch WP; Robertson SJ; Portis JL
J Virol; 1995 Mar; 69(3):1408-19. PubMed ID: 7853473
[TBL] [Abstract][Full Text] [Related]
8. Retrovirus-induced murine motor neuron disease: mapping the determinant of spongiform degeneration within the envelope gene.
Paquette Y; Hanna Z; Savard P; Brousseau R; Robitaille Y; Jolicoeur P
Proc Natl Acad Sci U S A; 1989 May; 86(10):3896-900. PubMed ID: 2542954
[TBL] [Abstract][Full Text] [Related]
9. Neurological disease induced in transgenic mice expressing the env gene of the Cas-Br-E murine retrovirus.
Kay DG; Gravel C; Pothier F; Laperrière A; Robitaille Y; Jolicoeur P
Proc Natl Acad Sci U S A; 1993 May; 90(10):4538-42. PubMed ID: 8389454
[TBL] [Abstract][Full Text] [Related]
10. Kinetic analysis of spongiform neurodegenerative disease induced by a highly virulent murine retrovirus.
Czub S; Lynch WP; Czub M; Portis JL
Lab Invest; 1994 May; 70(5):711-23. PubMed ID: 8196367
[TBL] [Abstract][Full Text] [Related]
11. Protection against murine leukemia virus-induced spongiform myeloencephalopathy in mice overexpressing Bcl-2 but not in mice deficient for interleukin-6, inducible nitric oxide synthetase, ICE, Fas, Fas ligand, or TNF-R1 genes.
Jolicoeur P; Hu C; Mak TW; Martinou JC; Kay DG
J Virol; 2003 Dec; 77(24):13161-70. PubMed ID: 14645573
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling of microglia infected by a highly neurovirulent murine leukemia virus: implications for neuropathogenesis.
Dimcheff DE; Volkert LG; Li Y; DeLucia AL; Lynch WP
Retrovirology; 2006 May; 3():26. PubMed ID: 16696860
[TBL] [Abstract][Full Text] [Related]
13. Development of spongiform encephalopathy in retroviral infected mice.
Nagra RM; Burrola PG; Wiley CA
Lab Invest; 1992 Mar; 66(3):292-302. PubMed ID: 1311397
[TBL] [Abstract][Full Text] [Related]
14. Murine retroviral neurovirulence correlates with an enhanced ability ofvirus to infect selectively, replicate in, and activate resident microglial cells.
Baszler TV; Zachary JF
Am J Pathol; 1991 Mar; 138(3):655-71. PubMed ID: 2000941
[TBL] [Abstract][Full Text] [Related]
15. Viral load and its relationship to quinolinic acid, TNF alpha, and IL-6 levels in the CNS of retroviral infected mice.
Nagra RM; Heyes MP; Wiley CA
Mol Chem Neuropathol; 1994 Aug; 22(3):143-60. PubMed ID: 7993524
[TBL] [Abstract][Full Text] [Related]
16. Neurotropic Cas-BR-E murine leukemia virus harbors several determinants of leukemogenicity mapping in different regions of the genome.
Jolicoeur P; DesGroseillers L
J Virol; 1985 Nov; 56(2):639-43. PubMed ID: 2997484
[TBL] [Abstract][Full Text] [Related]
17. Infection of central nervous system cells by ecotropic murine leukemia virus in C58 and AKR mice and in in utero-infected CE/J mice predisposes mice to paralytic infection by lactate dehydrogenase-elevating virus.
Anderson GW; Palmer GA; Rowland RR; Even C; Plagemann PG
J Virol; 1995 Jan; 69(1):308-19. PubMed ID: 7983723
[TBL] [Abstract][Full Text] [Related]
18. Retrovirus-induced spongiform encephalopathy: the 3'-end long terminal repeat-containing viral sequences influence the incidence of the disease and the specificity of the neurological syndrome.
DesGroseillers L; Rassart E; Robitaille Y; Jolicoeur P
Proc Natl Acad Sci U S A; 1985 Dec; 82(24):8818-22. PubMed ID: 3866255
[TBL] [Abstract][Full Text] [Related]
19. Neurodegeneration induced by PVC-211 murine leukemia virus is associated with increased levels of vascular endothelial growth factor and macrophage inflammatory protein 1 alpha and is inhibited by blocking activation of microglia.
Li X; Hanson C; Cmarik JL; Ruscetti S
J Virol; 2009 May; 83(10):4912-22. PubMed ID: 19279110
[TBL] [Abstract][Full Text] [Related]
20. Microglial response to murine leukemia virus-induced encephalopathy is a good indicator of neuronal perturbations.
Xue QS; Yang C; Hoffman PM; Streit WJ
Brain Res; 2010 Mar; 1319():131-41. PubMed ID: 20059990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
